What is Fate Therapeutics?
Fate Therapeutics is a cell therapy company company serving enterprise, commercial, consumer, healthcare, financial, real estate, or regulated-market customers.
- Category
- Cell therapy company
- Headquarters
- San Diego, United States
- Founded
- See official company history
- Employees
- See latest annual report and company filings
- Total funding
- Public company
- Status
- Public company; Nasdaq: FATE
What is Fate Therapeutics?
Fate Therapeutics is a cell therapy company company headquartered in San Diego, United States. Its public-company profile is most useful for account planning when combined with current filings, investor materials, job posts, product launches, and partner announcements.
Fate Therapeutics is a cell therapy company company headquartered in San Diego, United States. Its public-company profile is most useful for account planning when combined with current filings, investor materials, job posts, product launches, and partner announcements.
For sellers, Fate Therapeutics should be mapped as a scaled public-company account. The best timing signals are earnings commentary, capital spending, hiring clusters, product launches, acquisitions, facility investments, and leadership changes.
What does Fate Therapeutics offer?
Fate Therapeutics's profile centers on Cell therapy, NK cells, Cancer immunotherapy, Clinical development.
- Cell therapy· Cell therapy company
- NK cells· Cell therapy company
- Cancer immunotherapy· Cell therapy company
- Clinical development· Cell therapy company
- iPSC platform· Cell therapy company
- R&D· Cell therapy company
How does Fate Therapeutics make money?
Fate Therapeutics makes money through commercial activity tied to cell therapy company.
Fate Therapeutics monetizes through the model common to cell therapy company: product sales, recurring services, contracts, leases, subscriptions, transaction volume, servicing, investment management, or usage depending on the operating unit.
Sales angles should connect to measurable priorities such as margin, growth, occupancy, compliance, retention, automation, risk reduction, data quality, customer experience, or field productivity.
Who leads Fate Therapeutics?
Fate Therapeutics's named executives should be verified on the official leadership or investor-relations page before outreach.
- Fate Therapeutics executive leadershipExecutive leadership teamCurrent as of June 2026Use the official leadership, governance, or investor-relations page for current named executives before outreach.
- Fate Therapeutics finance leadershipFinance / CFO organizationCurrent as of June 2026Often owns investor communication, procurement governance, capital allocation, and budget discipline.
- Fate Therapeutics operations or technology leadershipOperations, product, technology, security, or commercial leadershipCurrent as of June 2026Likely stakeholder group for software, infrastructure, data, workflow, and operating-improvement purchases.
How do you contact Fate Therapeutics's leadership?
Fate Therapeutics should be contacted through official investor, media, partner, support, or sales routes unless a named executive publishes a direct address.
contact via https://www.fatetherapeutics.com- Fate Therapeutics investor relationsInvestor relations / corporate contactcontact via https://www.fatetherapeutics.com
- Fate Therapeutics sales or partnershipsCommercial contact routecontact via https://www.fatetherapeutics.com
- Fate Therapeutics media relationsMedia or communications contact routecontact via https://www.fatetherapeutics.com
How is Fate Therapeutics funded?
Fate Therapeutics's current status is Public company; Nasdaq: FATE.
Fate Therapeutics's capital profile is best understood through its current public-company status: Public company; Nasdaq: FATE. For public companies, financing and budget signals are usually found in annual reports, quarterly results, debt disclosures, buybacks, acquisitions, capital expenditure plans, and management commentary rather than venture funding rounds.
Before outreach, verify the latest status on the company's investor-relations page and current exchange filings.
How did Fate Therapeutics get here?
Fate Therapeutics's history should be read through founding, scale-up, public-market ownership, and current product or market focus.
- FoundingFate Therapeutics is foundedThe company begins building in cell therapy company.
- Scale-upCommercial footprint expandsFate Therapeutics broadens its product, customer, distribution, or geographic reach.
- Public marketsPublic company; Nasdaq: FATEPublic-company ownership shapes reporting, procurement, and operating priorities.
- 2025Scaled operating profileThe company operates with specialized teams and repeatable buying centers.
- June 2026Current profile refreshedProfile generated from official domain, public-company status, and source references.
Who are Fate Therapeutics's competitors?
Fate Therapeutics competes with larger incumbents and focused specialists in cell therapy company.
Fate Therapeutics — frequently asked questions
